Delivery Order SPE2DB20D1100-SPE2DB24FB9S4

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The $1,537.03 delivery order is for Tetracaine 0.5% Steri-Unit Solution 4ML, a prescription medication. The order is placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a wide range of medical commodities from...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,127.68 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a topical anesthetic medication. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,711,705 units of Tetracaine 0.5% Steri-Unit Solution, 4 mL, to the U.S. government. The contract has a ceiling value of $1,491.48 and a completion date of May 28, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $19,142.85, is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a medication used for local anesthesia. The contract is a Firm Fixed Price Delivery Order with a completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,351.05 firm fixed-price delivery order is for the supply of 4558843937 - TETRACAINE 0.5% STERI-UNIT SOL 4ML. The contract has an ultimate completion date of October 24, 2022 and was awarded on October 21, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,773.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product. It is a firm fixed-price delivery order contract with a completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tetracaine 0.5% Steri-Unit Solution (4 ml). The $1,883.35 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on February 23, 2022, with a completion date of February 24, 2022. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999...
This federal contract award, valued at $5,322.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of TETRACAINE 0.5% STERI-UNIT SOL 4ML, with an ultimate completion date of March 12, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $6,957.83, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product, with a completion date of September 25, 2024. This award is not designated as a set-aside contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tetracaine 1% (20 mg/2 ml) vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,547.48 and a completion date of July 25, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB9S4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Tetracaine 0.5% Steri-Unit Solution, a prescription medication. The contract is a delivery order with a firm fixed price of $1,052.91 and a completion date of May 29, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the DLA's mission of delivering logistics and acquisition services to the U.S. Armed Forces and other government agencies. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award was not set aside for any particular business type or socioeconomic status. Amerisourcebergen, as a for-profit organization, has demonstrated its competitive position in the federal pharmaceutical supply market through these multiple contract vehicles.

Generated 8/27/24, 9:30 AM